Corona Remedies Share Price, IPO Listing, GMP Live Updates: Corona Remedies is all set to hit the secondary market, after the ...

The last grey market premium (GMP) for the Corona Remedies IPO stood at Rs 307, as of 10:00 a.m. on December 4. Considering the upper end of the price band of Rs 1,062, the latest GMP indicates an ...

The initial public offering of Corona Remedies saw strong investor interest, being subscribed more than 137x from 8-10.

As per the latest update, the company’s shares are trading at Rs 1,353 in the unlisted markets. This indicates a premium of ...

Corona Remedies IPO price band is set at ₹1,008 to ₹1,062 per share. At the upper-end of the price band, the company aims to ...

Corona Remedies launched its IPO today to raise more than Rs 655 crore entirely through an offer for sale (OFS) of shares ...

Investors can check their application status on BSE, NSE, and Bigshare Services. The current grey market premium (GMP) signalled at more than 27% premium listing.

Retail investors have taken up 87% of their quota, while non institutional investors have subscribed 79% of their portion.

Corona Remedies has set its IPO price band between ₹1,008 to ₹1,062 per share, aiming to raise ₹655.37 crore through an Offer for Sale from December 8 to 10.

Two new companies, namely- Wakefit Innovations and Corona Remedies- are set to make their Dalal Street debut on Monday, ...